Citius Oncology, Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

0.7756

-0.0147 (-1.86%)

At close: Aug 28, 2026, 4:00 PM EDT

0.7800

+0.0044 (0.57%)

After-hours: Aug 28, 2026, 6:27 PM EDT

Citius Oncology Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Cash & Equivalents	16.56	3.92	0	-	-
Cash & Short-Term Investments	16.56	3.92	0	-	-
Cash Growth	14788922.32%	3504282.14%	-	-	-
Inventory	22.63	22.29	8.27	-	-
Prepaid Expenses	2.83	1.33	2.7	7.73	2.69
Total Current Assets	42.71	27.54	10.97	7.73	2.69
Long-Term Deferred Charges	69.39	73.4	73.4	40	40
Total Assets	112.09	100.94	84.37	47.73	42.69

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Accounts Payable	7.32	13.23	3.71	1.29	0.09
Accrued Expenses	35.82	13.61	0.59	19.76	5.75
Other Current Liabilities	15.65	22.65	28.4	-	-
Total Current Liabilities	58.79	49.49	32.7	21.05	5.85
Long-Term Debt	10.21	3.8	3.8	-	-
Long-Term Deferred Tax Liabilities	2.71	2.78	1.73	1.15	0.58
Other Long-Term Liabilities	-	-	-0	-	-
Total Liabilities	71.71	56.08	38.23	22.2	6.42

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	145.48	108.9	85.41	43.66	41.69
Retained Earnings	-105.11	-64.04	-39.28	-18.13	-5.43
Shareholders' Equity	40.38	44.87	46.14	25.54	36.27
Total Liabilities & Equity	112.09	100.94	84.37	47.73	42.69

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Total Debt	10.21	3.8	3.8	-	-
Net Cash (Debt)	6.35	0.12	-3.8	-	-
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	0.07	0.00	-0.06	-	-
Filing Date Shares Outstanding	105.76	84.8	71.55	67.5	67.5
Total Common Shares Outstanding	105.76	83.51	71.55	67.5	67.5
Working Capital	-16.08	-21.95	-21.73	-13.31	-3.16
Book Value Per Share	0.38	0.54	0.64	0.38	0.54
Tangible Book Value	40.38	44.87	46.14	25.54	36.27
Tangible Book Value Per Share	0.38	0.54	0.64	0.38	0.54

SEC Filings: 10-K · 10-Q